Chewy (CHWY) closed the most recent trading day at $38.51, moving -0.28% from the previous trading session. This change lagged the S&P 500's daily gain of 0.39%. On the other hand, the Dow registered a gain of 0.71%, and the technology-centric Nasdaq increased by 0.2%.The online pet store's stock has climbed by 7.97% in the past month, falling short of the Retail-Wholesale sector's gain of 8.29% and outpacing the S&P 500's gain of 1.7%.Analysts and investors alike will be keeping a close eye on the performa ...

Company Performance - Chewy's stock closed at $38.62, reflecting a +1.26% change from the previous trading day's close, outperforming the S&P 500 which gained 0.72% [1] - Over the last month, Chewy's shares increased by 2.89%, lagging behind the Retail-Wholesale sector's gain of 6.17% but outperforming the S&P 500's gain of 1.02% [1] Earnings Projections - Chewy's upcoming earnings per share (EPS) are projected to be $0.20, indicating an 11.11% increase from the same quarter last year [2] - The consensus estimate for quarterly revenue is $3.2 billion, representing a 13.11% increase from the year-ago period [2] Analyst Estimates - Recent changes to analyst estimates for Chewy reflect positive sentiment regarding the company's business operations and profit generation capabilities [3] - The Zacks Rank system, which incorporates these estimate changes, currently ranks Chewy at 3 (Hold) [5] Valuation Metrics - Chewy has a Forward P/E ratio of 30.76, which is a premium compared to the industry average Forward P/E of 21.67 [6] - The PEG ratio for Chewy is 0.83, while the Internet - Commerce industry average PEG ratio is 1.22 [6] Industry Context - The Internet - Commerce industry, part of the Retail-Wholesale sector, holds a Zacks Industry Rank of 70, placing it in the top 28% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Overview - Maev is the first and only human-grade raw dog food brand, founded in 2019 by Katie Spies, an MIT Engineer and dog parent [4] - The brand's mission is to provide easy-to-feed, efficacious daily nutrition for dogs, developed with the assistance of PhD veterinary nutritionists [4] Product Offering - Maev offers a range of premium raw-frozen dog food products, including Beef, Chicken, and Puppy formulas, designed to meet the nutritional needs of dogs [1] - The products are free from additives, fillers, and heat-driven nutrient loss, providing higher protein and nutrient value compared to kibble and home-cooked meals [1] - Maev's formulas are designed to deliver noticeable benefits in 28 days or less [1] Market Position and Growth - The frozen raw dog food market is experiencing remarkable growth, with Maev establishing itself as a leader in this segment [1] - The availability of Maev products on Chewy represents a significant milestone in making premium raw dog food accessible nationwide [2] Vision and Commitment - Maev aims to elevate pet nutrition and empower dog owners to make healthier choices for their pets [2] - The company is committed to improving the lives of dogs through high-quality nutrition [2]

Core Insights - Long-term investing is preferable to market timing, which is often ineffective [1] - Growth stocks can be volatile but offer significant returns if backed by strong businesses [2] Company Analysis: Eli Lilly - Eli Lilly has seen a resurgence in growth due to its GLP-1 drugs, with a 118% increase in annual profitability and a 71% increase in revenue over the past decade [3][4] - The company currently pays an annual dividend of $6 per share, yielding approximately 0.75%, with a payout ratio of about 54% [5] - Eli Lilly's drug portfolio includes successful treatments across various disease areas, with recent approvals for Kisunla, Ebglyss, and Omvoh expected to drive growth [6][7][8] - Preliminary revenue estimates for 2024 indicate a 32% increase compared to 2023, totaling $45 billion, despite a slight downward revision from previous guidance [9] - For the first nine months of 2024, Eli Lilly reported $32 billion in revenue, a 27% increase year-over-year, and net income of approximately $6.2 billion, doubling the previous year's profits [10] - The demand for Eli Lilly's products positions it well for continued growth and profitability [11] Company Analysis: Chewy - Chewy operates a pet e-commerce platform, with its Autoship subscription service accounting for 80% of net sales, totaling $2.3 billion in Q3 2024, a 9% increase from the previous year [12][14] - The majority of Chewy's sales come from non-discretionary purchases, which made up 85% of net sales in Q3 2024 [16] - Chewy is expanding its revenue sources through online pet pharmacy services, telehealth, health insurance, and a new advertising program expected to contribute 1% to 3% of net sales in fiscal 2024 [17] - The company is also opening vet clinics across the U.S., with six already operational, targeting a $25 billion addressable market [18][19] - Despite heavy investments in growth, Chewy generated $4 million in net income in Q3 2024, indicating resilience in its business model [20]

Group 1 - The article provides an update on Chewy Inc. (NYSE: CHWY) following a previous bullish recommendation based on the Investor Day review [1] - The author emphasizes a fundamentals-based approach to value investing, focusing on companies with long-term durability and robust balance sheets [1] - There is a disagreement with the notion that low multiple stocks are inherently cheap, highlighting the importance of valuation in investment decisions [1] Group 2 - The author expresses a belief that in certain situations, the potential for growth can outweigh immediate price concerns [1]

Key TakeawaysPet care player Chewy Inc. has seen its stock value grow 6% in the past month.Chewy stock closed at $37.01 during Friday's trading session, sitting 5.3% below its 52-week high of $39.10.With CHWY stock trading at elevated levels, has the margin of safety for new investors widened or grown slim?Chewy Inc. (CHWY) is a prominent player in the pet care industry, leveraging its e-commerce platform to cater to a growing base of pet owners. CHWY is currently trading at a forward 12-month price-to-earn ...

Shares of leading pet e-commerce behemoth Chewy (CHWY 5.58%) were up 5% as of 12:45 p.m. ET on Friday, according to data provided by S&P Global Market Intelligence.Following five separate price target increases from analysts in December, Chewy received its first upgrade of the new year from Wolfe Research, which named the stock one of its top picks for 2025.Does Chewy still have room to run?Despite Chewy's stock already doubling from its 2024 lows, Wolfe Research (and I) believe the best is yet to come. The ...

Chewy Inc (NYSE:CHWY) stock is 1.1% higher in pre-market trading, following a bull note at Wolfe Research. The analyst upgraded shares of the online pet retailer to "outperform" from "peer perform" and named it a top pick, citing potential for revenue and margin growth, as well as robust valuation. Over the last nine months, CHWY is up nearly 107% and boasts a 62.2% year-over-year lead. The equity has moved steadily higher since suffering an early November bear gap, working its way back towards its June 27, ...

Ex-hedge fund analyst with a strong interest in finding winners and losers in industries where corporate strategy matters most. I focus on analysing the market structure, competitive positioning and strategic catalysts that lead to money-making ideas in varying time horizons. Enjoy reading the research!Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase ...

PLANTATION, FLORIDA - JUNE 01: Exterior view of the Chewy Inc.’s headquarters building on June 01, ... [+] 2023 in Plantation, Florida. (Photo by Joe Raedle/Getty Images)Getty ImagesChewy’s stock (NYSE: CHWY) has experienced a notable 47% surge in the last year to around $32 (Dec 18), garnering significant investor attention. Chewy’s stock has plummeted 73% from its February 2021 peak of approximately $120 and currently trades at a level lower than its June 2019 initial public offering price ($35). The pand ...